Ousseny Zerbo

8.8k total citations · 3 hit papers
78 papers, 3.5k citations indexed

About

Ousseny Zerbo is a scholar working on Epidemiology, Health and Obstetrics and Gynecology. According to data from OpenAlex, Ousseny Zerbo has authored 78 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 23 papers in Health and 22 papers in Obstetrics and Gynecology. Recurrent topics in Ousseny Zerbo's work include Vaccine Coverage and Hesitancy (22 papers), COVID-19 Impact on Reproduction (22 papers) and Autism Spectrum Disorder Research (15 papers). Ousseny Zerbo is often cited by papers focused on Vaccine Coverage and Hesitancy (22 papers), COVID-19 Impact on Reproduction (22 papers) and Autism Spectrum Disorder Research (15 papers). Ousseny Zerbo collaborates with scholars based in United States, Kenya and Denmark. Ousseny Zerbo's co-authors include Lisa Croen, Yinge Qian, Maria L. Massolo, Cathleen K. Yoshida, Stephen S. Rich, Stephen Sidney, Clarissa Kripke, Bruce Fireman, Nicola P. Klein and Judy Van de Water and has published in prestigious journals such as JAMA, Nature Communications and Annals of Internal Medicine.

In The Last Decade

Ousseny Zerbo

72 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The health status of adults on the autism spectrum

2015 754 citations Lisa Croen, Ousseny Zerbo et al. profile →
Surveillance for Adverse Events After COVID-19 mRNA Vaccination

2021 434 citations Nicola P. Klein, Ned Lewis et al. profile →
Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021

2022 135 citations Heather S. Lipkind, Gabriela Vazquez‐Benitez et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ousseny Zerbo United States	27	1.5k	762	704	505	495	78	3.5k
Michael Brimacombe United States	30	1.0k 0.7×	447 0.6×	689 1.0×	382 0.8×	377 0.8×	108	4.0k
Peter Jacoby Australia	40	984 0.7×	1.5k 2.0×	697 1.0×	1.1k 2.2×	152 0.3×	151	4.4k
Nina Gunnes Norway	25	444 0.3×	269 0.4×	745 1.1×	182 0.4×	234 0.5×	54	2.3k
Elizabeth C. Breen United States	45	787 0.5×	935 1.2×	576 0.8×	164 0.3×	614 1.2×	141	7.6k
Kreesten Meldgaard Madsen Denmark	16	673 0.4×	391 0.5×	446 0.6×	246 0.5×	215 0.4×	23	2.0k
Pål Surén Norway	28	860 0.6×	521 0.7×	1.2k 1.8×	422 0.8×	145 0.3×	71	3.2k
Poul Thorsen Denmark	50	1.8k 1.2×	854 1.1×	996 1.4×	877 1.7×	326 0.7×	147	8.3k
Marianne Giørtz Pedersen Denmark	23	575 0.4×	620 0.8×	989 1.4×	545 1.1×	81 0.2×	38	3.2k
Nancy Doernberg United States	12	1.2k 0.8×	1.0k 1.3×	1.3k 1.9×	417 0.8×	131 0.3×	14	3.2k
Óscar H. Del Brutto Ecuador	48	215 0.1×	270 0.4×	586 0.8×	262 0.5×	848 1.7×	335	8.8k

Countries citing papers authored by Ousseny Zerbo

Since Specialization

Citations

This map shows the geographic impact of Ousseny Zerbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ousseny Zerbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ousseny Zerbo more than expected).

Fields of papers citing papers by Ousseny Zerbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ousseny Zerbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ousseny Zerbo. The network helps show where Ousseny Zerbo may publish in the future.

Co-authorship network of co-authors of Ousseny Zerbo

This figure shows the co-authorship network connecting the top 25 collaborators of Ousseny Zerbo. A scholar is included among the top collaborators of Ousseny Zerbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ousseny Zerbo. Ousseny Zerbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobson, Karen B., Andrew Watson, Maqdooda Merchant, et al.. (2025). Uptake of Maternal RSV Vaccination and Infant Nirsevimab Among Infants Born October 2023 to March 2024. JAMA Network Open. 8(1). e2453696–e2453696. 7 indexed citations

Hsiao, Amber, Ousseny Zerbo, John Hansen, et al.. (2025). Informing Maternal Immunization Trials: An Observational Study to Assess Background Rates of Maternal, Pregnancy, and Neonatal/Infant Outcomes. The Pediatric Infectious Disease Journal. 44(2S). S130–S134.

Zerbo, Ousseny, Julius Timbol, John Hansen, et al.. (2024). Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children. Influenza and Other Respiratory Viruses. 18(10). e70022–e70022. 1 indexed citations

Kharbanda, Elyse O., Malini B. DeSilva, Heather S. Lipkind, et al.. (2024). COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births. JAMA Pediatrics. 178(8). 823–823. 5 indexed citations

Ciesla, Allison Avrich, Kristin Dascomb, Stephanie A. Irving, et al.. (2024). Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022–August 2023. Open Forum Infectious Diseases. 11(9). ofae481–ofae481. 1 indexed citations

Vesco, Kimberly K., Anna E. Denoble, Heather S. Lipkind, et al.. (2024). Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics and Gynecology. 143(6). 794–802. 4 indexed citations

Getahun, Darios, In‐Lu Amy Liu, Lina S. Sy, et al.. (2024). Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies. JAMA Network Open. 7(9). e2434857–e2434857. 3 indexed citations

Kenigsberg, Tat’Yana A., Kayla E. Hanson, Nicola P. Klein, et al.. (2023). Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink. Vaccine. 41(32). 4658–4665. 8 indexed citations

Zerbo, Ousseny, G. Thomas Ray, Bruce Fireman, et al.. (2023). Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life. Nature Communications. 14(1). 894–894. 27 indexed citations

10.

DeSilva, Malini B., Jacob L. Haapala, Gabriela Vazquez‐Benitez, et al.. (2023). Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination. Obstetrics and Gynecology. 142(1). 125–129. 3 indexed citations

11.

Zerbo, Ousseny, G. Thomas Ray, Bruce Fireman, et al.. (2023). Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant. AJOG Global Reports. 3(4). 100264–100264. 3 indexed citations

12.

Zerbo, Ousseny, Kristin Goddard, Edwin Lewis, et al.. (2022). Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders. Vaccine. 40(18). 2568–2573. 3 indexed citations

13.

Xu, Stanley, Vennis Hong, Lina S. Sy, et al.. (2022). Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 40(23). 3150–3158. 9 indexed citations

14.

Zerbo, Ousseny, Ned Lewis, Bruce Fireman, et al.. (2021). Population‐based assessment of risks for severe COVID‐19 disease outcomes. Influenza and Other Respiratory Viruses. 16(1). 159–165. 21 indexed citations

15.

Ames, Jennifer, Assiamira Ferrara, Lyndsay A. Avalos, et al.. (2021). COVID-19 prevalence, symptoms, and sociodemographic disparities in infection among insured pregnant women in Northern California. PLoS ONE. 16(9). e0256891–e0256891. 25 indexed citations

16.

Zerbo, Ousseny, Joan Bartlett, Kristin Goddard, et al.. (2019). Acellular Pertussis Vaccine Effectiveness Over Time. PEDIATRICS. 144(1). e20183466–e20183466. 36 indexed citations

17.

Zerbo, Ousseny, Yinge Qian, Thomas S. Ray, et al.. (2018). Health Care Service Utilization and Cost Among Adults with Autism Spectrum Disorders in a U.S. Integrated Health Care System. Autism in Adulthood. 1(1). 27–36. 86 indexed citations

18.

Zerbo, Ousseny, Kristin Goddard, Ned Lewis, et al.. (2016). Kaiser Permanente Northern California pregnancy database: Description and proof of concept study. Vaccine. 34(46). 5519–5523. 6 indexed citations

19.

Zerbo, Ousseny, Albin Leong, Lisa F. Barcellos, et al.. (2015). Immune mediated conditions in autism spectrum disorders. Brain Behavior and Immunity. 46. 232–236. 117 indexed citations

20.

Croen, Lisa, Anthony Torres, Martin Kharrazi, et al.. (2013). A Genome-Wide Survey of Transgenerational Genetic Effects in Autism. PLoS ONE. 8(10). e76978–e76978. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact